Growing community of inventors

Palo Alto, CA, United States of America

Jinghong Wang

Average Co-Inventor Count = 7.50

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 12

Jinghong WangIan Nevin Foltz (3 patents)Jinghong WangZhulun Wang (3 patents)Jinghong WangNeeraj Jagdish Agrawal (3 patents)Jinghong WangXiaoshan Min (3 patents)Jinghong WangMurielle M Veniant-Ellison (3 patents)Jinghong WangDonghui Shi (3 patents)Jinghong WangDarren L Bates (3 patents)Jinghong WangJunming Yie (3 patents)Jinghong WangChristopher Murawsky (3 patents)Jinghong WangDavid J Lloyd (3 patents)Jinghong WangGlenn N Sivits, Jr (3 patents)Jinghong WangRenee Komorowski (3 patents)Jinghong WangBrandon C P Clavette (3 patents)Jinghong WangShu-yin Ho (3 patents)Jinghong WangYang Li (1 patent)Jinghong WangDaniel C H Lin (1 patent)Jinghong WangJinghong Wang (4 patents)Ian Nevin FoltzIan Nevin Foltz (67 patents)Zhulun WangZhulun Wang (24 patents)Neeraj Jagdish AgrawalNeeraj Jagdish Agrawal (18 patents)Xiaoshan MinXiaoshan Min (15 patents)Murielle M Veniant-EllisonMurielle M Veniant-Ellison (13 patents)Donghui ShiDonghui Shi (9 patents)Darren L BatesDarren L Bates (9 patents)Junming YieJunming Yie (8 patents)Christopher MurawskyChristopher Murawsky (7 patents)David J LloydDavid J Lloyd (6 patents)Glenn N Sivits, JrGlenn N Sivits, Jr (3 patents)Renee KomorowskiRenee Komorowski (3 patents)Brandon C P ClavetteBrandon C P Clavette (3 patents)Shu-yin HoShu-yin Ho (3 patents)Yang LiYang Li (134 patents)Daniel C H LinDaniel C H Lin (4 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Amgen Inc. (4 from 1,970 patents)


4 patents:

1. 12252540 - Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)

2. 11046774 - Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists

3. 10294303 - Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists

4. 9474792 - Method of treating metabolic disorders using PLA2G12A polypeptides and PLA2G12A mutant polypeptides

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…